{"entity":{"id":"chak-sing-lau","kind":"person","name":"Chak-sing Lau","aka":[],"tldr":"Rheumatologist who is Dean of Medicine at the University of Hong Kong, the academic partner of Queen Mary Hospital, and formerly chief of the hospital's Department of Medicine.","summary":"Professor Chak-sing Lau, BBS, JP, is the forty-first Dean of Medicine at The University of Hong Kong, whose LKS Faculty of Medicine is the teaching and research partner of Queen Mary Hospital, and is also interim Vice-President and Pro-Vice-Chancellor (Health). He holds the Daniel CK Yu Professorship in Rheumatology and Clinical Immunology and previously served as Chairperson of the Department of Medicine, Chief of Service in Medicine at Queen Mary Hospital and President of the Hong Kong Academy of Medicine. He is regarded as a pioneer of rheumatology in Hong Kong and founded the Hong Kong Arthritis and Rheumatism Foundation in 2001.","asOf":"2026-09-10","links":[{"label":"Source: HKUMed leadership page","url":"https://www.med.hku.hk/en/about-hkumed/leadership"}],"tags":["leadership","clinician-scientist","academic-medicine"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["queen-mary-hospital-hku"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["lancet","nejm"],"dependsOn":[],"notes":[],"role":"Dean of Medicine, LKS Faculty of Medicine, The University of Hong Kong","institutionId":"queen-mary-hospital-hku","specialisms":["Rheumatology","Clinical immunology","Academic medicine"],"profiles":[{"label":"HKUMed Dean's Corner","url":"https://www.med.hku.hk/en/about-hkumed/leadership/professor-lau-chak-sing"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Lau+CS%5BAuthor%5D"}],"papers":[{"title":"Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","journal":"The Lancet","year":2020,"url":"https://doi.org/10.1016/s0140-6736(20)31042-4","doi":"10.1016/s0140-6736(20)31042-4","note":"Europe PMC author record matched by affiliation"},{"title":"Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis","journal":"New England Journal of Medicine","year":2000,"url":"https://doi.org/10.1056/nejm200010193431604","doi":"10.1056/nejm200010193431604","note":"Europe PMC author record matched by affiliation"},{"title":"Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)","journal":"Annals of the Rheumatic Diseases","year":2016,"url":"https://doi.org/10.1136/annrheumdis-2015-207726","doi":"10.1136/annrheumdis-2015-207726","note":"Europe PMC author record matched by affiliation"}],"orcid":"0000-0001-6698-8355"},"route":"/people/chak-sing-lau/","neighbours":{"institution":[{"id":"queen-mary-hospital-hku","kind":"institution","name":"Queen Mary Hospital / University of Hong Kong","route":"/institutions/queen-mary-hospital-hku/"}],"journal":[{"id":"nejm","kind":"journal","name":"New England Journal of Medicine","route":"/journals/nejm/"},{"id":"lancet","kind":"journal","name":"The Lancet","route":"/journals/lancet/"}]}}